ES8304559A1 - "procedimiento para la fabricacion de sales de naftidrofurilo". - Google Patents

"procedimiento para la fabricacion de sales de naftidrofurilo".

Info

Publication number
ES8304559A1
ES8304559A1 ES512819A ES512819A ES8304559A1 ES 8304559 A1 ES8304559 A1 ES 8304559A1 ES 512819 A ES512819 A ES 512819A ES 512819 A ES512819 A ES 512819A ES 8304559 A1 ES8304559 A1 ES 8304559A1
Authority
ES
Spain
Prior art keywords
acid
acetone
ethyl acetate
therapeutic use
citric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES512819A
Other languages
English (en)
Spanish (es)
Other versions
ES512819A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9258433&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8304559(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of ES512819A0 publication Critical patent/ES512819A0/es
Publication of ES8304559A1 publication Critical patent/ES8304559A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Furan Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES512819A 1981-05-14 1982-05-14 "procedimiento para la fabricacion de sales de naftidrofurilo". Expired ES8304559A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8109590A FR2505836A1 (fr) 1981-05-14 1981-05-14 Citrate de naftidrofuryl et son application therapeutique

Publications (2)

Publication Number Publication Date
ES512819A0 ES512819A0 (es) 1983-03-01
ES8304559A1 true ES8304559A1 (es) 1983-03-01

Family

ID=9258433

Family Applications (1)

Application Number Title Priority Date Filing Date
ES512819A Expired ES8304559A1 (es) 1981-05-14 1982-05-14 "procedimiento para la fabricacion de sales de naftidrofurilo".

Country Status (22)

Country Link
US (1) US4439442A (enExample)
EP (1) EP0065446B1 (enExample)
JP (1) JPS57203078A (enExample)
KR (1) KR830010091A (enExample)
AT (1) ATE9342T1 (enExample)
AU (1) AU8373282A (enExample)
CA (1) CA1184562A (enExample)
CS (1) CS239923B2 (enExample)
DD (1) DD202432A5 (enExample)
DE (1) DE3260712D1 (enExample)
DK (1) DK210982A (enExample)
ES (1) ES8304559A1 (enExample)
FI (1) FI821664A7 (enExample)
FR (1) FR2505836A1 (enExample)
GR (1) GR75422B (enExample)
HU (1) HU187701B (enExample)
IL (1) IL65774A (enExample)
NZ (1) NZ200594A (enExample)
PT (1) PT74893B (enExample)
SU (1) SU1082323A3 (enExample)
YU (1) YU103082A (enExample)
ZA (1) ZA823195B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2580502B1 (fr) * 1985-04-23 1988-07-08 Lipha Emploi du " naftidrofuryl " dans la preparation d'un medicament
TW200920348A (en) * 2007-06-28 2009-05-16 Dybly Ag Combination of picotamide with nafronyl
US8203109B2 (en) 2009-05-08 2012-06-19 Raytheon Company High energy laser beam director system and method
CN104086515A (zh) * 2014-06-13 2014-10-08 刘博� 萘呋胺酯草酸盐的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL142872C (enExample) * 1963-03-28
FR3843M (fr) * 1964-03-17 1966-01-17 Lipha Nouvelles bases azotées a propriétés antispasmodique et vasodilatatrice.

Also Published As

Publication number Publication date
AU8373282A (en) 1982-11-18
FI821664A0 (fi) 1982-05-11
YU103082A (en) 1984-08-31
GR75422B (enExample) 1984-07-16
ATE9342T1 (de) 1984-09-15
IL65774A (en) 1985-09-29
HU187701B (en) 1986-02-28
US4439442A (en) 1984-03-27
ES512819A0 (es) 1983-03-01
DD202432A5 (de) 1983-09-14
CA1184562A (fr) 1985-03-26
FR2505836A1 (fr) 1982-11-19
SU1082323A3 (ru) 1984-03-23
EP0065446A1 (fr) 1982-11-24
ZA823195B (en) 1983-03-30
DK210982A (da) 1982-11-15
CS239923B2 (en) 1986-01-16
NZ200594A (en) 1985-03-20
PT74893A (fr) 1982-06-01
FI821664L (fi) 1982-11-15
KR830010091A (ko) 1983-12-26
FR2505836B1 (enExample) 1984-03-09
JPS57203078A (en) 1982-12-13
DE3260712D1 (en) 1984-10-18
PT74893B (fr) 1983-12-23
FI821664A7 (fi) 1982-11-15
EP0065446B1 (fr) 1984-09-12
US4439442B1 (enExample) 1987-06-30
IL65774A0 (en) 1982-08-31

Similar Documents

Publication Publication Date Title
FR2442227A1 (fr) Procede de production d'acides threo-3-amino-2-hydroxybutanoylaminoacetiques
FR2367750A1 (fr) Acid
ATE82569T1 (de) Herstellung von chinolincarbonsaeuren.
ATE38515T1 (de) Spiro-2-aza-alkan-3-carbonitrile, verfahren zu ihrer herstellung und ihre verwendung.
IT7949785A0 (it) Procedimento per la produzione di idrogeno mediante elettrolisi di acidi alogenici
JPS5524116A (en) Preparation of o-(2, 6-dichloroanilino)-phenylacetic acid
US4371705A (en) Synthesis of alpha-amino acids
US4370493A (en) Synthesis of alpha-amino acids
US2612522A (en) Alkanoyl-alpha-ethylbenzylureas
US2483347A (en) Intermediate products in the production of dialkylamino vitamin a's
ES8104273A1 (es) Un procedimiento para la preparacion de una ftalazina
GB1292846A (en) A process for the synthesis of leupeptins and their analogues
SU502879A1 (ru) Способ получени -(карбэтокси) - -моноалкилтиоацетамидов
US3897465A (en) Ethyl beta-(N-methylfurfurylamino) propionate
US3712906A (en) Derivatives of 4-(aminoethane-sulfonylamino)-antipyrine
JPS5257142A (en) Process for preparing dihalovinyl-cyclopropanecarboxylic acid derivati ves
JPS57106668A (en) Preparation of n,n'-bis-(3-(3',4',5'-trimethoxybenzoyloxy)- propyl)homopiperazine
US3373184A (en) Sulfamide derivatives
ES486298A1 (es) Un procedimiento para la preparacion de 2-metil-3-(b-hidro- ximetilcarbamoil)quinoxalina 1,4-di-n-oxido de gran pureza
SU461103A1 (ru) Способ получени мононатриевой соли -( -тиоэтил-2-амино)-тиофосфорной кислоты
KR840000369B1 (ko) 2-이소프로필아미노 피리미딘의 제법
DE933754C (de) Verfahren zur Herstellung von Derivaten des Tetrahydro-ª†-carbolins
ES8206529A1 (es) Un procedimiento para la preparacion de derivados de acido 6-amino-penicilanico
Winthrop et al. 2-BENZHYDRYLIMINO-4-THIAZOLIDONES AND RELATED COMPOUNDS
ES8502444A1 (es) Procedimiento para preparar derivados de acido 7-amino-cefalosporanico